epocrates note: Since this CDC guideline was issued, the FDA has approved the use of TDF/FTC in combo w/ safer sex practices to reduce the risk of sexually acquired HIV-1 (PrEP) in adolescents weighing at least 35 kg.

By vgreene, 3 March, 2020
Exclude Patient Type Detail Header
No
Detail Type
Text
Patient Type Detail Header (Long)
<b>epocrates note:</b> Since this CDC guideline was issued, the FDA has approved the use of TDF/FTC in combo w/ safer sex practices to reduce the risk of sexually acquired HIV-1 (PrEP) in adolescents weighing at least 35 kg.